We recently caught up with Mark Campbell, vice president at RxBenefits, to discuss the current state of specialty medications, key strategies for benefits advisors and employers, and what to expect in the second half of 2023 and beyond.
Unfortunately, there is not an industry-wide definition for "specialty" medications. Specialty status is determined by each PBM. Historically, the specialty designation was applied to medications that were classified as biologics or medications that required special storage and handling. Today, specialty designation can include high-cost oral therapies and medications that have limited distribution.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
